NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2022 pay falls 37% to $1.2M
NEUROONE MEDICAL TECHNOLOGIES Corp reports 2022 executive compensation
By ExecPay News
Published: January 27, 2023
NEUROONE MEDICAL TECHNOLOGIES Corp reported fiscal year 2022 executive compensation information on January 27, 2023.
In 2022, three executives at NEUROONE MEDICAL TECHNOLOGIES Corp received on average a compensation package of $652K, a 30% decrease compared to previous year.
Average pay of disclosed executives at NEUROONE MEDICAL TECHNOLOGIES Corp
Dave Rosa, Chief Executive Officer, received $1.2M in total, which decreased by 37% compared to 2021. 44% of Rosa's compensation, or $525K, was in stock awards. Rosa also received $189K in non-equity incentive plan and $472K in salary.
Steve Mertens, Chief Technology Officer, received a compensation package of $394K, which increased by 6% compared to previous year. 65% of the compensation package, or $255K, was in salary.
Ron McClurg, Chief Financial Officer, earned $376K in 2022, a 28% decrease compared to previous year.
NEUROONE MEDICAL TECHNOLOGIES Corp's fiscal year ends on September 30.
Related executives
You may also like
Source: SEC filing on January 27, 2023.